Bendle G - Search Results

1

Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.

Gilham DE, Anderson J, Bridgeman JS, Hawkins RE, Exley MA, Stauss H, Maher J, Pule M, Sewell AK, Bendle G, Lee S, Qasim W, Thrasher A, Morris E. Gilham DE, et al. Among authors: bendle g. Hum Gene Ther. 2015 May;26(5):276-85. doi: 10.1089/hum.2015.024. Hum Gene Ther. 2015. PMID: 25860661 Free PMC article. Review.

2

A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.

Morris EC, Tsallios A, Bendle GM, Xue SA, Stauss HJ. Morris EC, et al. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7934-9. doi: 10.1073/pnas.0500357102. Epub 2005 May 20. Proc Natl Acad Sci U S A. 2005. PMID: 15908507 Free PMC article.

3

Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.

Bendle GM, Holler A, Downs AM, Xue SA, Stauss HJ. Bendle GM, et al. Expert Opin Biol Ther. 2005 Sep;5(9):1183-92. doi: 10.1517/14712598.5.9.1183. Expert Opin Biol Ther. 2005. PMID: 16120049 Review.

4

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.

Wright GP, Notley CA, Xue SA, Bendle GM, Holler A, Schumacher TN, Ehrenstein MR, Stauss HJ. Wright GP, et al. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19078-83. doi: 10.1073/pnas.0907396106. Epub 2009 Nov 2. Proc Natl Acad Sci U S A. 2009. PMID: 19884493 Free PMC article.

5

Prospects for immunotherapy of malignant disease.

Morris EC, Bendle GM, Stauss HJ. Morris EC, et al. Among authors: bendle gm. Clin Exp Immunol. 2003 Jan;131(1):1-7. doi: 10.1046/j.1365-2249.2003.02055.x. Clin Exp Immunol. 2003. PMID: 12519379 Free PMC article. Review.

6

Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2.

Xue SA, Bendle GM, Holler A, Stauss HJ. Xue SA, et al. Immunology. 2008 Jul;124(3):315-21. doi: 10.1111/j.1365-2567.2007.02793.x. Epub 2008 Jan 24. Immunology. 2008. PMID: 18217949 Free PMC article.

7

Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes.

Bendle GM, Holler A, Pang LK, Hsu S, Krampera M, Simpson E, Stauss HJ. Bendle GM, et al. Cancer Res. 2004 Nov 1;64(21):8052-6. doi: 10.1158/0008-5472.CAN-04-0630. Cancer Res. 2004. PMID: 15520215

8

Exploiting alloreactivity for tumour immunotherapy.

Stauss HJ, Xue S, Gillmore R, Gao L, Bendle G, Holler A, Downs AM, Morris E. Stauss HJ, et al. Among authors: bendle g. Vox Sang. 2004 Jul;87 Suppl 2:227-9. doi: 10.1111/j.1741-6892.2004.00493.x. Vox Sang. 2004. PMID: 15209922 Review. No abstract available.

9

Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells.

Alsaieedi A, Holler A, Velica P, Bendle G, Stauss HJ. Alsaieedi A, et al. Among authors: bendle g. Oncoimmunology. 2018 Dec 5;8(3):1542917. doi: 10.1080/2162402X.2018.1542917. eCollection 2019. Oncoimmunology. 2018. PMID: 30723575 Free PMC article.

10

WT1-targeted immunotherapy of leukaemia.

Xue S, Gao L, Gillmore R, Bendle G, Holler A, Downs AM, Tsallios A, Ramirez F, Ghani Y, Hart D, Alcock S, Tranter A, Stauss HJ, Morris E. Xue S, et al. Among authors: bendle g. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):288-90. doi: 10.1016/j.bcmd.2004.08.018. Blood Cells Mol Dis. 2004. PMID: 15528146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page